A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis

Arthritis and Rheumatism

Volumn 64, Issue 9, 2012, Pages 2986-2994

  Steen, Virginia ^a   Domsic, Robyn T ^b   Lucas, Mary ^b   Fertig, Noreen ^b   Medsger, Thomas A ^b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA TOPOISOMERASE; ENZYME ANTIBODY; PROTEIN ANTIBODY; RIBONUCLEOPROTEIN; TOPOISOMERASE I ANTIBODY; U1 RNP ANTIBODY; U3 RNP ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ANTIBODY BLOOD LEVEL; ARTHROPATHY; ARTICLE; CAUCASIAN; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; KIDNEY DISEASE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MUSCLE DISEASE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RACE DIFFERENCE; SEROLOGY; SKIN DISEASE; SURVIVAL; SYSTEMIC SCLEROSIS; TENDON DISEASE; VASCULAR DISEASE;

EID: 84865648979     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34482     Document Type: Article

References (28)

1. Steen VD, Oddis CV, Conte CG, Janoski J, Casterline GZ, Medsger TA Jr,. Incidence of systemic sclerosis in Allegheny County, Pennsylvania: a twenty-year study of hospital-diagnosed cases, 1963-1982. Arthritis Rheum 1997; 40: 441-5.
2. Laing TJ, Gillespie BW, Toth MB, Mayes MD, Gallavan RH Jr, Burns CJ, et al. Racial differences in scleroderma among women in Michigan. Arthritis Rheum 1997; 40: 734-42.
3. Greidinger EL, Flaherty KT, White B, Rosen A, Wigley FM, Wise RA,. African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest 1998; 114: 801-7.
4. Beall AD, Nietert PJ, Taylor MH, Mitchell HC, Shaftman SR, Silver RM, et al. Ethnic disparities among patients with pulmonary hypertension associated with systemic sclerosis. J Rheumatol 2007; 34: 1277-82.
5. Steen VD,. The many faces of scleroderma. Rheum Dis Clin North Am 2008; 34: 1-15.
6. Steen VD, Powell DL, Medsger TA Jr,. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988; 31: 196-203.
7. Reveille JD, Durban E, Goldstein R, Moreda R, Arnett FC,. Racial differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum 1992; 35: 216-8.
8. Picillo U, Migliaresi S, Vatti M, Marcialis MR, Ferruzzi AM, Tirri G,. Demographic differences in the frequencies of scleroderma-related autoantibodies [letter]. Arthritis Rheum 1993; 36: 1332-3.
9. Reveille JD, Arnett FC,. Frequencies of scleroderma-related autoantibodies in patients meeting the American College of Rheumatology criteria for systemic sclerosis: reply [letter]. Arthritis Rheum 1993; 36: 1333-4.
10. McNearney TA, Reveille JD, Fischbach M, Friedman AW, Lisse JR, Goel N, et al. Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum 2007; 57: 318-26.
11. Okano Y, Steen VD, Medsger TA Jr,. Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum 1992; 35: 95-100.
12. Reveille JD, Fischbach M, McNearney T, Friedman AW, Aguilar MB, Lisse J, et al. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum 2001; 30: 332-46.
13. Steen VD, Ziegler GL, Rodnan GP, Medsger TA Jr,. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum 1984; 27: 125-31.
14. Sharif R, Fritzler MJ, Mayes MD, Gonzalez EB, McNearney TA, Draeger H, et al. Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis. J Rheumatol 2011; 38: 1622-30.
15. Steen VD,. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005; 35: 35-42.
16. Steen VD, Medsger TA Jr,. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000; 43: 2437-44.
17. Steen VD, Medsger TA,. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007; 66: 940-4.
18. Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999; 26: 2159-67.
19. Clements P, Lachenbruch P, Seibold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22: 1281-5.
20. Okano Y, Steen VD, Medsger TA Jr,. Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 1993; 119: 1005-13.
21. Okano Y, Medsger TA Jr,. Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis. Arthritis Rheum 1990; 33: 1822-8.
22. Fries JF, Spitz P, Kraines RG, Holman HR,. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-45.
23. Nishimagi E, Tochimoto A, Kawaguchi Y, Satoh T, Kuwana M, Takagi K, et al. Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement. J Rheumatol 2007; 34: 2050-5.
24. Nietert PJ, Mitchell HC, Bolster MB, Shaftman SR, Tilley BC, Silver RM,. Racial variation in clinical and immunological manifestations of systemic sclerosis. J Rheumatol 2006; 33: 263-8.
25. Ward MM,. Education level and mortality in systemic lupus erythematosus (SLE): evidence of underascertainment of deaths due to SLE in ethnic minorities with low education levels. Arthritis Rheum 2004; 51: 616-24.
26. Azih C, Peng J, Steen V,. Small bowel involvement in systemic sclerosis [abstract]. Arthritis Rheum 2008; 58 Suppl: S377.
27. Bogatkevich GS, Ludwicka-Bradley A, Highland KB, Hant F, Nietert PJ, Singleton CB, et al. Impairment of the antifibrotic effect of hepatocyte growth factor in lung fibroblasts from African Americans: possible role in systemic sclerosis. Arthritis Rheum 2007; 56: 2432-42.
28. Mendoza F, Derk CT,. Systemic sclerosis mortality in the United States: 1999-2002 implications for patient care. J Clin Rheumatol 2007; 13: 187-92.